| SC 13G/A | 2023-10-10 | VANGUARD GROUP INC | INTERCEPT PHARMACEUTICALS, INC. | 2,071,222 | 5.0% | EDGAR |
| SC 13G/A | 2023-07-10 | VANGUARD GROUP INC | INTERCEPT PHARMACEUTICALS, INC. | 4,693,807 | 11.3% | EDGAR |
| SC 13G/A | 2023-07-07 | BlackRock Inc. | INTERCEPT PHARMACEUTICALS, INC. | 4,396,970 | 10.5% | EDGAR |
| SC 13G/A | 2023-02-14 | Point72 Asset Management, L.P. | INTERCEPT PHARMACEUTICALS, INC. | 166,300 | 0.4% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | INTERCEPT PHARMACEUTICALS, INC. | 3,637,935 | 8.8% | EDGAR |
| SC 13G/A | 2023-02-02 | STATE STREET CORP | INTERCEPT PHARMACEUTICALS, INC. | - | 7.7% | EDGAR |
| SC 13G/A | 2023-01-31 | BlackRock Inc. | INTERCEPT PHARMACEUTICALS, INC. | 3,084,833 | 7.4% | EDGAR |
| SC 13G/A | 2023-01-13 | MILLENNIUM MANAGEMENT LLC | INTERCEPT PHARMACEUTICALS, INC. | 976,706 | 2.4% | EDGAR |
| SC 13G | 2022-10-12 | Point72 Asset Management, L.P. | INTERCEPT PHARMACEUTICALS, INC. | 2,019,983 | 4.9% | EDGAR |
| SC 13G/A | 2022-10-11 | FMR LLC | INTERCEPT PHARMACEUTICALS, INC. | 934,378 | 2.4% | EDGAR |
| SC 13G/A | 2022-09-02 | Genextra S.p.A. | INTERCEPT PHARMACEUTICALS, INC. | 4,000,000 | 13.4% | EDGAR |
| SC 13G | 2022-08-18 | MILLENNIUM MANAGEMENT LLC | INTERCEPT PHARMACEUTICALS, INC. | 1,524,316 | 5.1% | EDGAR |
| SC 13G/A | 2022-02-11 | STATE STREET CORP | INTERCEPT PHARMACEUTICALS, INC. | - | 11.0% | EDGAR |
| SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | INTERCEPT PHARMACEUTICALS, INC. | 1,971,759 | 6.7% | EDGAR |
| SC 13G/A | 2022-02-09 | FMR LLC | INTERCEPT PHARMACEUTICALS, INC. | 2,639,433 | 8.9% | EDGAR |
| SC 13G/A | 2022-02-03 | BlackRock Inc. | INTERCEPT PHARMACEUTICALS, INC. | 2,232,092 | 7.6% | EDGAR |
| SC 13G/A | 2022-02-02 | FIRST TRUST PORTFOLIOS LP | INTERCEPT PHARMACEUTICALS, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-12-10 | STATE STREET CORP | INTERCEPT PHARMACEUTICALS, INC. | - | 10.9% | EDGAR |
| SC 13G/A | 2021-06-10 | VANGUARD GROUP INC | INTERCEPT PHARMACEUTICALS, INC. | 3,363,077 | 10.1% | EDGAR |
| SC 13G | 2021-02-11 | STATE STREET CORP | INTERCEPT PHARMACEUTICALS, INC. | - | 7.7% | EDGAR |